High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication.
Wynn
C
C
Fujisawa Research Institute of America, Northwestern University/Evanston Research Park, 1801 Maple Avenue, Evanston, IL 60201, USA.
Pan
F
F
Erickson
L
L
Ebbs
A
A
Kobayashi
M
M
Jiang
H
H
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000494:pharmacology; D006084:Graft Rejection / Q000201:enzymology / Q000276:immunology* / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007700:Kinetics; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000494:pharmacology; D013997:Time Factors; D016212:Transforming Growth Factor beta / Q000187:drug effects / Q000502:physiology*; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D000911:Antibodies, Monoclonal; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016212:Transforming Growth Factor beta; D016572:Cyclosporine; D016559:Tacrolimus